Several factors can influence PFS in gynecological cancers. These include the type and stage of cancer, the patient’s overall health, and the _treatment modalities_ used. For instance, advanced-stage cancers generally have shorter PFS compared to early-stage cancers. Additionally, the type of chemotherapy, targeted therapy, or _immunotherapy_ can also significantly impact PFS.
